Brief: AngioDynamics Q1 Adjusted EPS USD -0.12 Vs. IBES Estimate USD -0.13
04/10/2023 12:00
Oct 04 (Reuters) - AngioDynamics Q1 adjusted EBITDA USD 800 thousand. * Q1 sales USD 78.7 million vs. IBES estimate USD 77.7 million * Q1 adjusted net income USD -4.8 million * Q1 net income USD 45.9 million * Q1 gross margin 50.9% * outlook FY gross margin 50-52% * outlook FY sales USD 328-333 million
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary